Merz Pharma Gains Radiesse Dermal Filler Via $253 Mil. BioForm Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Merz Pharma Group will round out its aesthetic product offerings by adding the Radiesse wrinkle filler device through its $253 million acquisition of BioForm Medical, announced Jan. 4